Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review

BACKGROUND: Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract, although its etiology has largely been unclear. Tumor necrosis factor inhibitors (TNF-I) are effective for the treatment. Recently, biosimilars of TNF-I, such as CT-P13, have been developed and are th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashima, Shin, Moriichi, Kentaro, Ando, Katsuyoshi, Ueno, Nobuhiro, Tanabe, Hiroki, Yuzawa, Sayaka, Fujiya, Mikihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513323/
https://www.ncbi.nlm.nih.gov/pubmed/34641810
http://dx.doi.org/10.1186/s12876-021-01948-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513323/
https://www.ncbi.nlm.nih.gov/pubmed/34641810
http://dx.doi.org/10.1186/s12876-021-01948-6

Ejemplares similares